Untreated patients with profound BTD deficiency have a high risk to develop severe neurological signs and symptoms, including spasticity, seizures, optic atrophy, hearing loss, and cognitive deficits, as well as cutaneous symptoms, such as eczematous skin rash and alopecia.6 The gene discussed is BTD; the disease is hyperinsulinemic hypoglycemia, familial, 4.